This bill seeks to prevent the implementation, administration, or enforcement of a specific Food and Drug Administration (FDA) final rule by prohibiting the use of Federal funds for these activities. The targeted rule, titled "Medical Devices; Laboratory Developed Tests," was submitted for publication in the Federal Register on May 6, 2024, and identified as 89 Fed. Reg. 37286. The legislation explicitly states that no Federal funds may be used for any aspect of this rule, or for any regulation deemed substantially similar to it. This measure effectively aims to halt the progression and application of the FDA's regulatory framework concerning laboratory developed tests.